Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients

Diabetologia

Volumn 44, Issue 3, 2001, Pages 305-308

  Brunner, G A ^a   Balent, B ^a   Ellmerer, M ^a   Schaupp, L ^a   Siebenhofer, A ^a   Jendle, J H ^a   Okikawa, J ^a   Pieber, T R ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Inhaled insulin; Insulin therapy; Pharmacodynamics; Pharmacokinetics; Pulmonary insulin; Type I diabetes

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; TIME FACTORS;

EID: 0035084004     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051618     Document Type: Article

References (10)

1. Insulin analogues and their potential in the management of diabetes mellitus
2. Novel forms of insulin delivery
3. Intrapulmonary insulin administration to healthy volunteers
4. Post-prandial administration of the insulin analogue insulin aspart in diabetes mellitus
5. Inhaled insulin
6. Time-action profile of inhaled insulin
7. The lung as an alternative route of delivery for insulin in controlling post-prandial glucose levels in patients with diabetes
8. Treatment of type I diabetes mellitus with inhaled insulin: A 3-month multicenter trial
9. Treatment of type II diabetes mellitus with inhaled insulin: A 3-month multicenter trial
10. Safety of inhaled proteins for therapeutic use